Publications by authors named "Peter Held"

Claim this Profile
C
CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.
J Antonio Gutierrez, Gretchen M Heizer, W Schuyler Jones, Frank W Rockhold, Kenneth W Mahaffey, Peter Held

Am Heart J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Limb Ischemia in Peripheral Artery Disease.
Connie N Hess, Zhen Huang, Manesh R Patel, Iris Baumgartner, Jeffrey S Berger, Peter Held

Circulation· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
Carlos A Molina, S Claiborne Johnston, Per Ladenvall, Pierre Amarenco, Gregory W Albers, Peter Held

Stroke· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Christoph B Olivier, Hillary Mulder, William R Hiatt, W Schuyler Jones, F Gerry R Fowkes, Peter Held

JAMA Cardiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Jeffrey S Berger, Beth L Abramson, Renato D Lopes, Gretchen Heizer, Frank W Rockhold, Peter Held

Vasc Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
Cecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, Jeffrey S Berger, Iris Baumgartner, Peter Held

J Am Coll Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
J Antonio Gutierrez, Hillary Mulder, W Schuyler Jones, Frank W Rockhold, Iris Baumgartner, Peter Held

JAMA Netw Open· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
K S Lawrence Wong, Pierre Amarenco, Gregory W Albers, Hans Denison, J Donald Easton, Peter Held

Stroke· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
Sameer Bansilal, Marc P Bonaca, Jan H Cornel, Robert F Storey, Deepak L Bhatt, Peter Held

J Am Coll Cardiol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
Lars Norgren, Manesh R Patel, William R Hiatt, Daniel M Wojdyla, F Gerry R Fowkes, Peter Held

Eur J Vasc Endovasc Surg· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
J Donald Easton, Maria Aunes, Gregory W Albers, Pierre Amarenco, Sara Bokelund-Singh, Peter Held

Circulation· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
Pierre Amarenco, Gregory W Albers, Hans Denison, J Donald Easton, Scott R Evans, Peter Held

Stroke· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
Pierre Amarenco, Gregory W Albers, Hans Denison, J Donald Easton, Scott R Evans, Peter Held

Lancet Neurol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
W Schuyler Jones, Iris Baumgartner, William R Hiatt, Gretchen Heizer, Michael S Conte, Peter Held

Circulation· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Yongjun Wang, Kazuo Minematsu, Ka Sing Lawrence Wong, Pierre Amarenco, Gregory W Albers, Peter Held

Stroke· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
William R Hiatt, F Gerry R Fowkes, Gretchen Heizer, Jeffrey S Berger, Iris Baumgartner, Peter Held

N Engl J Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Marc P Bonaca, Shinya Goto, Deepak L Bhatt, P Gabriel Steg, Robert F Storey, Peter Held

Circulation· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
S Claiborne Johnston, Pierre Amarenco, Gregory W Albers, Hans Denison, J Donald Easton, Peter Held

N Engl J Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program.
Peter Held, Anders Himmelmann, Marc Ditmarsch

Future Cardiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.
Marc P Bonaca, Deepak L Bhatt, Ton Oude Ophuis, P Gabriel Steg, Robert Storey, Peter Held

JAMA Cardiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.
Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, Dominick J Angiolillo, Marc Cohen, Peter Held

J Am Coll Cardiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Marc P Bonaca, Deepak L Bhatt, Robert F Storey, Ph Gabriel Steg, Marc Cohen, Peter Held

J Am Coll Cardiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Jeffrey S Berger, Brian G Katona, W Schuyler Jones, Manesh R Patel, Lars Norgren, Peter Held

Am Heart J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
Marc P Bonaca, Deepak L Bhatt, P Gabriel Steg, Robert F Storey, Marc Cohen, Peter Held

Eur Heart J· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Giulia Magnani, Robert F Storey, Gabriel Steg, Deepak L Bhatt, Marc Cohen, Peter Held

Eur Heart J· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis